{"id":28727,"date":"2019-12-12T00:00:00","date_gmt":"2019-12-12T00:00:00","guid":{"rendered":"http:\/\/medgoo.com\/index.php\/2019\/12\/12\/non-hdl-cholesterol-levels-linked-to-long-term-ascvd-risk-2\/"},"modified":"2019-12-13T17:10:07","modified_gmt":"2019-12-13T17:10:07","slug":"non-hdl-cholesterol-levels-linked-to-long-term-ascvd-risk-2","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2019\/12\/12\/non-hdl-cholesterol-levels-linked-to-long-term-ascvd-risk-2\/","title":{"rendered":"Non-HDL Cholesterol Levels Linked to Long-Term ASCVD Risk"},"content":{"rendered":"<h3>Fifty percent reduction in non-HDLC concentration linked to reduced risk for CVD event by age 75 years<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>WEDNESDAY, Dec. 4, 2019 (HealthDay News) &#8212; Elevated concentrations of non-high-density lipoprotein (non-HDL) cholesterol are associated with an increased long-term risk for atherosclerotic cardiovascular disease, according to a study published online Dec. 3 in <i>The Lancet<\/i>.<\/p>\n<p>Fabian J. Brunner, M.D., from the University Heart &#038; Vascular Center Hamburg in Germany, and colleagues examined the cardiovascular disease risk associated with the spectrum of bloodstream non-HDL cholesterol concentrations. In addition, a tool was created to estimate the probabilities of a cardiovascular disease event by age 75 years.<\/p>\n<p>A total of 398,846 individuals belonging to 38 cohorts were identified; the derivation and validation cohorts included 199,415 and 199,431 individuals, respectively. The researchers identified 54,542 cardiovascular end points during a maximum follow-up of 43.6 years. For increasing non-HDL cholesterol categories, incidence curve analyses showed progressively higher 30-year cardiovascular disease event rates. For both sexes, in multivariable analysis with non-HDL cholesterol lower than 2.6 mmol\/L as reference, there was an increase noted in the association between non-HDL cholesterol concentration and cardiovascular disease. Cardiovascular disease event probabilities specific for non-HDL cholesterol could be estimated with the derived tool, with high comparability seen between the derivation and validation cohorts. A 50 percent decrease in non-HDL cholesterol concentration correlated with reduced cardiovascular disease event risk by age 75 years; the risk reduction was greater with earlier reductions in cholesterol concentrations.<\/p>\n<p>&#8220;Our study provides unique insights into the benefits of a potential early intervention in primary prevention,&#8221; the authors write.<\/p>\n<p>Several authors disclosed financial ties to the pharmaceutical industry.<\/p>\n<p><a href=\"https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(19)32519-X\/fulltext\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><a href=\"https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(19)32949-6\/fulltext\" target=\"_new\" rel=\"noopener noreferrer\">Editorial (subscription or payment may be required)<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2019 <a href=\"https:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener noreferrer\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Fifty percent reduction in non-HDLC concentration linked to reduced risk for CVD event by age 75 years<\/p>\n","protected":false},"author":6,"featured_media":28768,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-28727","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/28727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=28727"}],"version-history":[{"count":0,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/28727\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/28768"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=28727"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=28727"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=28727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}